Clinical Scenario 1: First- and Second-Line Treatment for GVHD
April 28th 2022John F. DiPersio, MD, PhD, presents the clinical scenario of a 71-year-old patient postmatched unrelated donor HSCT, and the panel discusses first- and second-line treatment approaches including topical and systemic therapies.